175 related articles for article (PubMed ID: 17465211)
21. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival.
Lenz HJ; Hayashi K; Salonga D; Danenberg KD; Danenberg PV; Metzger R; Banerjee D; Bertino JR; Groshen S; Leichman LP; Leichman CG
Clin Cancer Res; 1998 May; 4(5):1243-50. PubMed ID: 9607583
[TBL] [Abstract][Full Text] [Related]
22. Thymidine phosphorylase expression in invasive carcinoma: correlations with clinicopathologic variables and in vitro chemosensitivity to 5-fluorouracil.
Yang Q; Shan L; Yoshimura G; Taniguchi E; Suzuma T; Nakamura Y; Nakamura M; Utsunomiya H; Tang W; Sakurai T; Kakudo K
Anticancer Res; 1999; 19(6C):5543-6. PubMed ID: 10697613
[TBL] [Abstract][Full Text] [Related]
23. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.
Nishimura G; Terada I; Kobayashi T; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
Oncol Rep; 2002; 9(3):479-82. PubMed ID: 11956613
[TBL] [Abstract][Full Text] [Related]
24. Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients.
Paradiso A; Simone G; Petroni S; Leone B; Vallejo C; Lacava J; Romero A; Machiavelli M; De Lena M; Allegra CJ; Johnston PG
Br J Cancer; 2000 Feb; 82(3):560-7. PubMed ID: 10682666
[TBL] [Abstract][Full Text] [Related]
25. Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa.
Miyamoto S; Ochiai A; Boku N; Ohtsu A; Tahara M; Yoshida S; Okabe H; Takechi T; Fukushima M
Int J Oncol; 2001 Apr; 18(4):705-13. PubMed ID: 11251164
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses.
Etienne MC; Chazal M; Laurent-Puig P; Magné N; Rosty C; Formento JL; Francoual M; Formento P; Renée N; Chamorey E; Bourgeon A; Seitz JF; Delpero JR; Letoublon C; Pezet D; Milano G
J Clin Oncol; 2002 Jun; 20(12):2832-43. PubMed ID: 12065560
[TBL] [Abstract][Full Text] [Related]
27. Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes.
Fujiwaki R; Hata K; Nakayama K; Moriyama M; Iwanari O; Katabuchi H; Okamura H; Sakai E; Miyazaki K
Int J Cancer; 2002 May; 99(3):328-35. PubMed ID: 11992400
[TBL] [Abstract][Full Text] [Related]
28. Thymidylate synthase gene expression in primary colorectal cancer and metastatic sites.
Yamada H; Ichikawa W; Uetake H; Shirota Y; Nihei Z; Sugihara K; Hirayama R
Clin Colorectal Cancer; 2001 Nov; 1(3):169-73; discussion 174. PubMed ID: 12450430
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of the salvage synthesis within biosynthesis of nucleic acid route in colon cancer].
Katsumata K; Sumi T; Murohashi T; Nagashima K; Uda O; Ashizawa T; Yamamoto K; Koyanagi Y
Gan To Kagaku Ryoho; 2000 Aug; 27(9):1415-20. PubMed ID: 10969598
[TBL] [Abstract][Full Text] [Related]
30. Clinical applications of the histoculture drug response assay.
Furukawa T; Kubota T; Hoffman RM
Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
[TBL] [Abstract][Full Text] [Related]
31. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis.
Ikeguchi M; Makino M; Kaibara N
Langenbecks Arch Surg; 2002 Oct; 387(5-6):240-5. PubMed ID: 12410361
[TBL] [Abstract][Full Text] [Related]
32. [Thymidylate synthase and dihydropyrimidine dehydrogenase activity in a metastatic liver tumor from colorectal cancer].
Umekita N; Tanaka S; Abe H; Kitamura M
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1883-5. PubMed ID: 11086436
[TBL] [Abstract][Full Text] [Related]
33. Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer.
Aschele C; Lonardi S; Monfardini S
Cancer Treat Rev; 2002 Feb; 28(1):27-47. PubMed ID: 12027413
[TBL] [Abstract][Full Text] [Related]
34. [Activities of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with colorectal cancer].
Uehara M; Takahashi S; Takenaka A; Izumi H; Fujii K; Ikawa O; Miyata K; Iizuka R; Matsumura H; Kakihara N; Shono Y; Tsuchihashi H; Saisaka Y
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2035-41. PubMed ID: 11791381
[TBL] [Abstract][Full Text] [Related]
35. Dihydropyrimidine dehydrogenase activity and thymidylate synthase level are associated with response to 5-fluorouracil in human colorectal cancer.
Araki Y; Isomoto H; Shirouzu K
Kurume Med J; 2001; 48(2):93-8. PubMed ID: 11501504
[TBL] [Abstract][Full Text] [Related]
36. A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil.
Etienne MC; Pivot X; Formento JL; Bensadoun RJ; Formento P; Dassonville O; Francoual M; Poissonnet G; Fontana X; Schneider M; Demard F; Milano G
Br J Cancer; 1999 Apr; 79(11-12):1864-9. PubMed ID: 10206306
[TBL] [Abstract][Full Text] [Related]
37. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.
Kawakami K; Salonga D; Park JM; Danenberg KD; Uetake H; Brabender J; Omura K; Watanabe G; Danenberg PV
Clin Cancer Res; 2001 Dec; 7(12):4096-101. PubMed ID: 11751507
[TBL] [Abstract][Full Text] [Related]
38. [Dihydropyrimidine dehydrogenase and thymidylate synthase in colon carcinoma].
Hamaji M; Nishida T; Miyazaki S; Nishida Y
Gan To Kagaku Ryoho; 2002 Jun; 29(6):889-93. PubMed ID: 12090040
[TBL] [Abstract][Full Text] [Related]
39. Thymidylate synthase as a predictor of response.
Leichman CG
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):43-7. PubMed ID: 9726090
[TBL] [Abstract][Full Text] [Related]
40. Determinants of prognosis and response to therapy in colorectal cancer.
Iqbal S; Lenz HJ
Curr Oncol Rep; 2001 Mar; 3(2):102-8. PubMed ID: 11177741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
